IN2014MN00377A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN00377A IN2014MN00377A IN377MUN2014A IN2014MN00377A IN 2014MN00377 A IN2014MN00377 A IN 2014MN00377A IN 377MUN2014 A IN377MUN2014 A IN 377MUN2014A IN 2014MN00377 A IN2014MN00377 A IN 2014MN00377A
- Authority
- IN
- India
- Prior art keywords
- complex
- metalloproteinase inhibitor
- relates
- renal
- kda
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 abstract 3
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 abstract 2
- 108050006602 Metalloproteinase inhibitor 2 Proteins 0.000 abstract 2
- 102000017304 72kDa type IV collagenases Human genes 0.000 abstract 1
- 108050005269 72kDa type IV collagenases Proteins 0.000 abstract 1
- 102100022712 Alpha-1-antitrypsin Human genes 0.000 abstract 1
- 101710181333 Chaperone protein dnaK1 Proteins 0.000 abstract 1
- 101710089247 Heat shock 70 kDa protein 1 Proteins 0.000 abstract 1
- 101710093639 Heat shock 70 kDa protein 1A Proteins 0.000 abstract 1
- 102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 abstract 1
- 101710093640 Heat shock 70 kDa protein 1B Proteins 0.000 abstract 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 abstract 1
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 abstract 1
- 108010028275 Leukocyte Elastase Proteins 0.000 abstract 1
- 102000016799 Leukocyte elastase Human genes 0.000 abstract 1
- 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 abstract 1
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 abstract 1
- 102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 abstract 1
- 101710112096 Myeloid differentiation primary response protein MyD88 Proteins 0.000 abstract 1
- 102100021852 Neuronal cell adhesion molecule Human genes 0.000 abstract 1
- 101710130688 Neuronal cell adhesion molecule Proteins 0.000 abstract 1
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 abstract 1
- 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 abstract 1
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 abstract 1
- 229940024142 alpha 1-antitrypsin Drugs 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 208000037806 kidney injury Diseases 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161528003P | 2011-08-26 | 2011-08-26 | |
| US201161528000P | 2011-08-26 | 2011-08-26 | |
| PCT/US2012/052298 WO2013043310A1 (en) | 2011-08-26 | 2012-08-24 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00377A true IN2014MN00377A (enrdf_load_stackoverflow) | 2015-06-19 |
Family
ID=47914751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN377MUN2014 IN2014MN00377A (enrdf_load_stackoverflow) | 2011-08-26 | 2012-08-24 |
Country Status (16)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103760359B (zh) | 2008-10-21 | 2017-01-11 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| NZ625423A (en) | 2009-12-20 | 2015-02-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2585827A4 (en) | 2010-06-23 | 2013-12-04 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency |
| WO2013043310A1 (en) * | 2011-08-26 | 2013-03-28 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US10935548B2 (en) | 2011-12-08 | 2021-03-02 | Astute Medical, Inc. | Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2 |
| AU2014207509B2 (en) | 2013-01-17 | 2019-12-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US11261257B2 (en) | 2013-01-28 | 2022-03-01 | Diasorin S.P.A. | Methods for detecting 1,25-dihydroxyvitamin D and related antibodies |
| US10983136B2 (en) * | 2013-01-28 | 2021-04-20 | Diasorin S.P.A. | Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker |
| EP2759550B1 (en) | 2013-01-28 | 2018-08-15 | DiaSorin S.p.A. | Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies |
| CN110007084B (zh) | 2013-12-03 | 2022-11-18 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| US11333671B2 (en) | 2014-10-20 | 2022-05-17 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| AU2016207734A1 (en) * | 2015-01-18 | 2017-08-03 | Diasorin S.P.A. | Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker |
| EP3281011B1 (en) | 2015-04-09 | 2024-06-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN105466984B (zh) * | 2016-01-14 | 2018-12-28 | 郑以山 | 用于肾脏非显性损伤的预警装置及其使用方法 |
| AU2017277305A1 (en) | 2016-06-06 | 2018-12-20 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
| US11353465B2 (en) | 2017-01-12 | 2022-06-07 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on C—C motif chemokine ligand 14 measurement |
| US11346846B2 (en) | 2017-02-06 | 2022-05-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US11718682B2 (en) | 2017-04-05 | 2023-08-08 | Astute Medical, Inc. | Assays for TIMP2 having improved performance in biological samples |
| WO2019227055A1 (en) | 2018-05-24 | 2019-11-28 | Renibus Therapeutics, Inc. | Methods of treating patients at risk for renal injury and renal failure |
| CN109251956A (zh) * | 2018-09-18 | 2019-01-22 | 青岛大学 | 糖尿病大鼠胰岛内MyD88 mRNA表达及黄芪的调节作用 |
| WO2020092909A1 (en) * | 2018-11-02 | 2020-05-07 | Prevencio, Inc. | Prognostic and diagnostic methods for risk of acute kidney injury |
| CN114113575B (zh) * | 2020-08-28 | 2023-06-02 | 菲鹏生物股份有限公司 | 标记复合物及其制备方法与应用 |
| CN116434960B (zh) * | 2023-06-13 | 2023-10-13 | 中国人民解放军总医院 | 一种心源性休克临床决策支持系统、设备及可存储介质 |
| WO2025033619A1 (ko) * | 2023-08-07 | 2025-02-13 | 경상국립대학교병원 | 신 대체요법 개시 결정을 위한 정보 제공 방법 및 이의 결정을 위한 말기 신질환 진단용 조성물 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| JPH06506688A (ja) | 1991-04-10 | 1994-07-28 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | クロストークインヒビターおよびその使用 |
| ATE195808T1 (de) | 1991-04-12 | 2000-09-15 | Biosite Diagnostics Inc | Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
| JP5392980B2 (ja) | 2003-03-27 | 2014-01-22 | チルドレンズ ホスピタル メディカル センター | 早発型の腎尿細管細胞障害を検出するための方法およびキット |
| WO2005002416A2 (en) * | 2003-06-04 | 2005-01-13 | Joslin Diabetes Center, Inc. | Predictors of renal disease |
| US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US20060003345A1 (en) * | 2004-06-30 | 2006-01-05 | Pfizer Inc | RNA bioassay |
| CN101557825A (zh) * | 2005-08-19 | 2009-10-14 | 森托科尔公司 | 抗蛋白酶解的抗体制剂 |
| WO2007144781A2 (en) * | 2006-04-21 | 2007-12-21 | Diagnotech Pty. Ltd. | Diagnostic methods and kits utilizing antibodies for metalloproteases |
| ES2532221T3 (es) * | 2007-03-26 | 2015-03-25 | Novartis Ag | Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal |
| JP2011503587A (ja) * | 2007-11-15 | 2011-01-27 | バイオポルト ディアグノスティックス エイ／エス | 独特の分子形態を有するタンパク質バイオマーカーの診断における使用 |
| CN101960308B (zh) | 2008-02-29 | 2014-07-09 | 国立大学法人名古屋大学 | 急性肾损伤及预后推测用生物标记物以及其用途 |
| CN102187220B (zh) * | 2008-08-28 | 2015-08-19 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| WO2010025434A1 (en) * | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN103760359B (zh) * | 2008-10-21 | 2017-01-11 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| CN102264230B (zh) * | 2008-11-10 | 2014-12-10 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| US9229010B2 (en) * | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| ES2499415T3 (es) * | 2009-06-02 | 2014-09-29 | Biocrates Life Sciences Ag | Nuevos biomarcadores para la evaluación de enfermedades renales |
| EA201290056A1 (ru) * | 2009-08-07 | 2012-08-30 | Астьют Медикал, Инк. | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности |
| MX2012003168A (es) * | 2009-09-18 | 2012-05-08 | Astute Medical Inc | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. |
| MX2009012633A (es) * | 2009-11-23 | 2011-05-24 | Univ Mexico Nacional Autonoma | Metodo de diagnostico para detectar la lesion renal aguda a traves del uso de la proteina de choque termico de 72 kda como un biomarcador sensible. |
| NZ625423A (en) * | 2009-12-20 | 2015-02-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| AU2011220413B2 (en) * | 2010-02-26 | 2015-07-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2013043310A1 (en) * | 2011-08-26 | 2013-03-28 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
-
2012
- 2012-08-24 WO PCT/US2012/052298 patent/WO2013043310A1/en active Application Filing
- 2012-08-24 EP EP12832845.7A patent/EP2748605B1/en active Active
- 2012-08-24 CA CA2846602A patent/CA2846602A1/en not_active Abandoned
- 2012-08-24 EP EP18209718.8A patent/EP3489690A1/en active Pending
- 2012-08-24 KR KR1020147007890A patent/KR20140074307A/ko not_active Withdrawn
- 2012-08-24 EA EA201490384A patent/EA201490384A1/ru unknown
- 2012-08-24 BR BR112014004389A patent/BR112014004389A2/pt not_active IP Right Cessation
- 2012-08-24 ES ES12832845T patent/ES2721907T3/es active Active
- 2012-08-24 AU AU2012312907A patent/AU2012312907A1/en not_active Abandoned
- 2012-08-24 PL PL12832845T patent/PL2748605T3/pl unknown
- 2012-08-24 CN CN201610804095.1A patent/CN106443011A/zh active Pending
- 2012-08-24 CN CN201280049909.5A patent/CN103874923B/zh active Active
- 2012-08-24 TR TR2019/03235T patent/TR201903235T4/tr unknown
- 2012-08-24 MX MX2014002146A patent/MX346096B/es active IP Right Grant
- 2012-08-24 IN IN377MUN2014 patent/IN2014MN00377A/en unknown
- 2012-08-24 JP JP2014527328A patent/JP2014529073A/ja active Pending
- 2012-08-24 US US14/241,005 patent/US9459261B2/en active Active
- 2012-08-24 PT PT12832845T patent/PT2748605T/pt unknown
-
2016
- 2016-10-03 US US15/284,197 patent/US9784750B2/en active Active
- 2016-10-19 JP JP2016204848A patent/JP2017032586A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ621716A (en) | 2016-04-29 |
| PL2748605T4 (pl) | 2019-08-30 |
| EP3489690A1 (en) | 2019-05-29 |
| PT2748605T (pt) | 2019-05-03 |
| ES2721907T3 (es) | 2019-08-06 |
| MX2014002146A (es) | 2014-08-21 |
| MX346096B (es) | 2017-03-07 |
| NZ706242A (en) | 2016-07-29 |
| BR112014004389A2 (pt) | 2017-03-28 |
| US20170016917A1 (en) | 2017-01-19 |
| EP2748605A1 (en) | 2014-07-02 |
| WO2013043310A1 (en) | 2013-03-28 |
| EA201490384A1 (ru) | 2014-08-29 |
| CN103874923B (zh) | 2016-09-14 |
| JP2014529073A (ja) | 2014-10-30 |
| US9459261B2 (en) | 2016-10-04 |
| PL2748605T3 (pl) | 2019-08-30 |
| TR201903235T4 (tr) | 2019-03-21 |
| CA2846602A1 (en) | 2013-03-28 |
| EP2748605A4 (en) | 2015-12-02 |
| US9784750B2 (en) | 2017-10-10 |
| AU2012312907A1 (en) | 2014-03-13 |
| US20140213477A1 (en) | 2014-07-31 |
| KR20140074307A (ko) | 2014-06-17 |
| JP2017032586A (ja) | 2017-02-09 |
| CN106443011A (zh) | 2017-02-22 |
| EP2748605B1 (en) | 2018-12-05 |
| CN103874923A (zh) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00377A (enrdf_load_stackoverflow) | ||
| MX341926B (es) | Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal. | |
| WO2011106746A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2012174282A3 (en) | Biomarker compositions and methods | |
| WO2013022995A3 (en) | Biomarker compositions and methods | |
| WO2014193999A3 (en) | Biomarker methods and compositions | |
| MX342967B (es) | Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal. | |
| WO2009024691A3 (fr) | Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal | |
| MX2013000916A (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
| NZ619918A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2008100352A3 (en) | Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis | |
| EA201291314A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| PH12013501878A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
| Costa et al. | Emerging molecular biomarker targets for amyotrophic lateral sclerosis | |
| BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
| MX2014000283A (es) | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. | |
| WO2007103770A8 (en) | Compositions and methods for analyzing renal cancer | |
| WO2008028926A3 (en) | Methods and compositions for the prediction of response to trastuzumab containing chemotherapy regimen in malignant neoplasia | |
| EP2723866A4 (en) | METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF NEURODEEGENERATIVE DISEASES, METHOD FOR IDENTIFYING COMPOUND CANDIDATES AND COMPOUNDS FOR THE TREATMENT OF NEURODEGENATIVE DISEASES | |
| EA201290195A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| MX388231B (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| WO2009019367A3 (fr) | Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal | |
| MA30393B1 (fr) | Procede de traitement, de diagnostic ou de detection du cancer | |
| NZ598035A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| FR2900936B1 (fr) | Procede et methodes de detection de la maladie d'alzheimer |